Oss, Netherlands

Jacobus Albertus Peters

This inventor holds 3 USPTO granted patents. Top assignee: Akzo Nobel N.v.. Active years: 1998-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacobus Albertus Peters. Retrieved from https://idiyas.com/inventor/jacobus-albertus-peters

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1998-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jacobus Albertus Peters: Innovator in Thrombin Inhibition

Introduction

Jacobus Albertus Peters is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of medicinal chemistry, particularly in the development of thrombin inhibitors. With a total of 3 patents to his name, Peters has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents, Peters has developed imidazo[1,5-a]pyridine derived serine protease inhibitors. These innovations focus on thrombin inhibitors, which are crucial in the treatment of various thrombotic conditions. The invention relates to a thrombin inhibitor of a specific formula, showcasing his commitment to advancing medical science.

Career Highlights

Jacobus Albertus Peters is currently associated with Akzo Nobel N.V., a leading global company in the field of paints and coatings. His work at Akzo Nobel has allowed him to collaborate with other talented professionals and contribute to groundbreaking research.

Collaborations

Peters has worked alongside notable colleagues such as Henricus Carl Ottenheym and Anton Egbert Adang. These collaborations have further enriched his research and development efforts, leading to innovative solutions in the pharmaceutical industry.

Conclusion

Jacobus Albertus Peters is a distinguished inventor whose work in thrombin inhibitors has made a significant impact in the field of medicinal chemistry. His contributions continue to influence advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…